Predictors of response to neoadjuvant checkpoint inhibition with chemotherapy in triple-negative breast cancer (TNBC): A meta-analysis of randomized control trials (RCTs)

被引：0
|
作者：
Roy, A. M. [1 ]
Attwood, K. [2 ]
Gandhi, S. [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Med Oncol Hematol, Buffalo, NY USA
[2] Roswell Pk Comprehens Canc Ctr, Biostat, Buffalo, NY USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.03.176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
158P
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [11] Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
    Yuanfang Xin
    Guoshuang Shen
    Yonghui Zheng
    Yumei Guan
    Xingfa Huo
    Jinming Li
    Dengfeng Ren
    Fuxing Zhao
    Zhen Liu
    Zitao Li
    Jiuda Zhao
    BMC Cancer, 21
  • [12] Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
    Xin, Yuanfang
    Shen, Guoshuang
    Zheng, Yonghui
    Guan, Yumei
    Huo, Xingfa
    Li, Jinming
    Ren, Dengfeng
    Zhao, Fuxing
    Liu, Zhen
    Li, Zitao
    Zhao, Jiuda
    BMC CANCER, 2021, 21 (01)
  • [13] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [14] Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials
    Marinelli, Daniele
    Mazzotta, Marco
    Pizzuti, Laura
    Krasniqi, Eriseld
    Gamucci, Teresa
    Natoli, Clara
    Grassadonia, Antonino
    Tinari, Nicola
    Tomao, Silverio
    Sperduti, Isabella
    Sanguineti, Giuseppe
    Botticelli, Andrea
    Fabbri, Agnese
    Botti, Claudio
    Ciliberto, Gennaro
    Barba, Maddalena
    Vici, Patrizia
    CANCERS, 2020, 12 (09) : 1 - 13
  • [15] Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
    Wu, Kunpeng
    Yang, Qiaozhu
    Liu, Yi
    Wu, Aibing
    Yang, Zhixiong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [16] Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
    Kunpeng Wu
    Qiaozhu Yang
    Yi Liu
    Aibing Wu
    Zhixiong Yang
    World Journal of Surgical Oncology, 12
  • [17] Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
    Weng, Zeng-Jie
    Wu, Sheng-Xi
    Luo, He-San
    Du, Ze-Sen
    Li, Xu-Yuan
    Lin, Jia-Zhou
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2021, 58
  • [18] A meta-analysis of platinum-based neoadjuvant chemotherapy versus standard neoadjuvant chemotherapy for triple-negative breast cancer
    Wang, Dong
    Feng, Jiafu
    Xu, Bei
    FUTURE ONCOLOGY, 2019, 15 (23) : 2779 - 2790
  • [19] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [20] Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis
    Li, Yunhai
    Yang, Dejuan
    Chen, Ping
    Yin, Xuedong
    Sun, Jiazheng
    Li, Hongzhong
    Ren, Guosheng
    AGING-US, 2019, 11 (16): : 6286 - 6311
12345